GL1X · GenesisL1 explorer

MolNFT v1 · #147361 · protein

Crystal structure of fusion inhibitor jnj-2408068 in complex with human respiratory syncytial virus fusion glycoprotein escape variant T400A stabilized in the prefusion state

6EAK · Fusion glycoprotein F0: “Crystal structure of fusion inhibitor jnj-2408068 in complex with human respiratory syncytial virus fusion…”. X-ray diffraction, 3 ligands (5NK, NI, SO4), 2 pockets (best druggability 0.46). MolNFT v1…

PDB
6EAK
Type
protein
Length
438 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0
UniProt
W8RJF9
Ligands
5NK, NI, SO4
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0protein43830% helix, 34% strandW8RJF9

Ligands and binding sites

  • 5NK · 2-[[2-[[1-(2-azanylethyl)piperidin-4-yl]amino]-4-methyl-benzimidazol-1-yl]methyl]-6-methyl-pyridin-3-ol · ligand · chains F
  • NI · Nickel (II) ion · metal · chains F
  • SO4 · Sulfate ion · ion · 6 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11820.460.7523empty
2530.270.7413empty

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 6EAK · Crystal structure of fusion inhibitor jnj-2408068 in complex with human respiratory… · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.